Natalia Buza, MD

Associate Professor of Pathology; Associate Director of Gynecologic Pathology

Research Departments & Organizations


Yale Cancer Center

Office of Cooperative Research

Research Interests

Gestational Trophoblastic Disease; Morphological and Microscopic Findings; Ovarian Neoplasms; Pathological Conditions, Anatomical; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms

Research Summary

Dr. Buza's research interest primarily involves identification of new diagnostic, prognostic and predictive biomarkers and therapeutic targets in ovarian and endometrial cancer. In addition, she has a special interest in the pathogenesis and pathologic diagnosis of gestational trophoblastic disease. In collaboration with her colleagues, she has been working on integrating new – molecular genetic diagnostic modalities in the pathology work-up of gestational trophoblastic disease.

Clinical Trials

Conditions Study Title
Corpus Uteri A phase II evaluation of pembrolizumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent hypermutated/ultramutated endometrial cancer identified by next generation sequencing (NGS) and comprehensive genomic profiling (CGP), A Pilot Study
Cervix Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel "Prime and Pull" Strategy

Selected Publications

See list of PubMed publications

Edit this profile

Contact Info

Natalia Buza, MD
Office Location
Yale PathologyYale Pathology Labs
310 Cedar Street, Ste LH 219B

New Haven, CT 06510
Mailing Address
Pathology310 Cedar Street
PO Box 208023

New Haven, CT 06520-8023